CJC-1295 with DAC

Product Overview

CJC-1295 with DAC is a synthetic long-acting analog of growth hormone-releasing hormone (GHRH). The addition of Drug Affinity Complex (DAC) technology extends circulating half-life through albumin binding, making it widely studied in growth hormone signaling research models.

Research Classification

Synthetic Peptide (GHRH Analog, Long-Acting)

$80.00

Clear

Sequence / Chemical Identity

  • Peptide Length: 30 amino acids (modified GHRH 1–29)
  • Structural Class: Tetrasubstituted GHRH analog with DAC conjugation

Molecular Data

  • Molecular Weight: ~3,367 g/mol
  • CAS Number: 863288-34-0

Receptor / Pathway Targets

  • Primary Research Targets: GHRH receptor
  • Investigated Pathways: Growth hormone signaling cascade

Purity Standard

≥98% (HPLC)

Appearance

Lyophilized powder

Storage

Store at −20°C. Protect from light and moisture.

Regulatory Status

For laboratory research use only. Not approved for human or veterinary use.

Additional information

Weight

10mg